Minaxen (Minocycline)

Minocycline, the active ingredient in Minaxen, is a tetracycline antibiotic presented as an oral tablet for oral use. It treats bacterial infections and acne vulgaris in adults and adolescents.

GNH USA supplies Minaxen as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Minocycline is a broad‑spectrum tetracycline antibiotic used for infections affecting the skin, respiratory tract and other tissues.

Acne vulgaris: reduces inflammatory lesions and bacterial colonisation on the skin. Skin and soft‑tissue infections: eradicates susceptible Gram‑positive and Gram‑negative bacteria. Respiratory tract infections: treats community‑acquired pneumonia and other susceptible respiratory pathogens.

Minocycline may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea or vomiting - Diarrhoea - Photosensitivity (increased sunburn risk) - Dizziness or vertigo - Vestibular disturbances (e.g., imbalance) - Skin rash or mild itching

Serious or Rare Side Effects: - Severe hypersensitivity reactions (e.g., anaphylaxis) - Drug‑induced lupus erythematosus - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Hepatic toxicity (elevated liver enzymes, hepatitis) - Intracranial hypertension (headache, visual changes) - Blood dyscrasias such as agranulocytosis or aplastic anaemia

Before prescribing Minaxen, clinicians should consider several safety factors.

Pregnancy: use only if clearly needed; safety category is not established. Breastfeeding: caution advised as the drug may pass into milk. Renal impairment: dose adjustment may be required. Hepatic impairment: monitor liver function tests. Photosensitivity: advise patients to avoid prolonged sun exposure and use protective clothing. Store below 25°C: keep in the original pack, protect from moisture.

Minaxen can interact with several medicines, altering efficacy or safety.

Major Interactions (Avoid): - Anticoagulants (warfarin): increased bleeding risk. - Oral contraceptives: reduced hormonal efficacy. - Retinoids (isotretinoin): heightened risk of intracranial hypertension. - Penicillins: antagonistic antibacterial effect. - Lithium: elevated lithium serum concentrations.

Moderate Interactions (Monitor Closely): - Antacids containing aluminium or magnesium: reduced minocycline absorption. - Probenecid: increased minocycline plasma levels. - Methoxyflurane: enhanced nephrotoxicity. - Vitamin D supplements: possible hypercalcaemia. - Cyclosporine: increased risk of renal impairment.